KBC Group’s Halozyme HALO Stock Holding History

KBC Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$309K	Hold	3,945	–	–	﹤0.01%	904
2026 Q1	$255K	Hold	3,945	–	–	﹤0.01%	903
2025 Q4	$265K	Buy	3,945 +584	+17%	+$39.3K	﹤0.01%	825
2025 Q3	$246K	Hold	3,361	–	–	﹤0.01%	834
2025 Q2	$175K	Sell	3,361 -2,284	-40%	-$130K	﹤0.01%	920
2025 Q1	$360K	Buy	5,645 +92	+2%	+$5.34K	﹤0.01%	787
2024 Q4	$265K	Buy	5,553 +2,145	+63%	+$110K	﹤0.01%	990
2024 Q3	$195K	Buy	3,408 +310	+10%	+$17.8K	﹤0.01%	944
2024 Q2	$162K	Buy	3,098 +252	+9%	+$11.1K	﹤0.01%	931
2024 Q1	$116K	Hold	2,846	–	–	﹤0.01%	1051
2023 Q4	$105K	Hold	2,846	–	–	﹤0.01%	1045
2023 Q3	$109K	Buy	+2,846	New	+$117K	﹤0.01%	976
2022 Q4	–	Sell	-13,061	Closed	-$516K	–	1534
2022 Q3	$516K	Sell	13,061 -121	-0.9%	-$5.35K	﹤0.01%	753
2022 Q2	$580K	Buy	13,182 +8,820	+202%	+$381K	﹤0.01%	741
2022 Q1	$174K	Hold	4,362	–	–	﹤0.01%	1073
2021 Q4	$175K	Buy	+4,362	New	+$163K	﹤0.01%	1091

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

KBC Group's HALO Position: Q2 2026 in Review

KBC Group held its Halozyme (HALO) position steady in Q2 2026 at 3,945 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #904.

KBC Group first reported a position in HALO in Q4 2021 and has held it in 16 quarters since. The position peaked at $580K in Q2 2022. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

KBC Group held 3,945 shares of Halozyme worth $309K as of Q2 2026.
KBC Group left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #904 holding.
KBC Group first reported a position in Halozyme in Q4 2021 and has held it in 16 quarters since.
KBC Group's Halozyme position peaked at $580K in Q2 2022.
672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.